15 Dec, 2016 Bristol-Myers Squibb Agrees To Another Abilify Settlement By Andrew Steinberg | Dangerous Prescription Drug | 0 Comments Pharmaceutical giant Bristol-Myers Squibb agreed to a multistate settlement over unfair and deceptive marketing practices concerning its popular antipsychotic medication Abilify. The company agreed to pay $19.5 million to... Read More
